References
1. Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695-1705.
2. Manoharan G, Van Mieghem NM, Windecker S, et al. 1-Year outcomes with the Evolut R self-expanding transcatheter aortic valve: from the International FORWARD Study. JACC Cardiovasc Interv. 2018;11(22):2326-2334.
3. MacDonald I, Pasupati S. Transcatheter aortic valve implantation: know the differences between the currently available technologies. Eur Heart J. 2010;31(14):1663-1665.
4. van Gils L, Tchetche D, Lhermusier T, et al. Transcatheter heart valve selection and permanent pacemaker implantation in patients with pre-existent right bundle branch block. J Am Heart Assoc. 2017;6(3):e005028.
5. Tops LF, Schalij MJ, Bax JJ. The effects of right ventricular apical pacing on ventricular function and dyssynchrony implications for therapy. J Am Coll Cardiol. 2009;54(9):764-776.
6. Mauri V, Reimann A, Stern D, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv. 2016;9(21):2200-2209.
7. Husser O, Pellegrini C, Kessler T, et al. Predictors of permanent pacemaker implantations and new-onset conduction abnormalities with the SAPIEN 3 balloon-expandable transcatheter heart valve. JACC Cardiovasc Interv. 2016;9(3):244-254.
8. Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, predictors, and outcomes of permanent pacemaker implantation following transcatheter aortic valve replacement: analysis from the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry. JACC Cardiovasc Interv. 2016;9(21):2189-2199.
9. Nazif TM, Dizon JM, Hahn RT, et al. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015;8(1 Pt A):60-69.
10. Mangieri A, Lanzillo G, Bertoldi L, et al. Predictors of advanced conduction disturbances requiring a late (≥48 H) permanent pacemaker following transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11(15):1519-1526.
11. De-Torres-Alba F, Kaleschke G, Vormbrock J, et al. Delayed pacemaker requirement after transcatheter aortic valve implantation with a new-generation balloon expandable valve: should we monitor longer?. Int J Cardiol. 2018;273:56-62.
12. Tichelbäcker T, Bergau L, Puls M, et al. Insights into permanent pacemaker implantation following TAVR in a real-world cohort. PLoS One. 2018;13(10):e0204503. Published 2018 Oct 17.
13. Mauri V, Deuschl F, Frohn T, et al. Predictors of paravalvular regurgitation and permanent pacemaker implantation after TAVR with a next-generation self-expanding device. Clin Res Cardiol. 2018;107(8):688-697.
14. Gensas CS, Caixeta A, Siqueira D, et al. Predictors of permanent pacemaker requirement after transcatheter aortic valve implantation: insights from a Brazilian registry. Int J Cardiol. 2014;175(2):248-252.
15. Gaede L, Kim WK, Liebetrau C, et al. Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol. 2018;107(1):60-69.
16. Ramazzina C, Knecht S, Jeger R, et al. Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation. Pacing Clin Electrophysiol. 2014;37(12):1592-1601.
17. Boerlage-Van Dijk K, Kooiman KM, Yong ZY, et al. Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol. 2014;37(11):1520-1529.
18. Maan A, Refaat MM, Heist EK, et al. Incidence and predictors of pacemaker implantation in patients undergoing transcatheter aortic valve replacement. Pacing Clin Electrophysiol. 2015;38(7):878-886.
19. Kaneko H, Hoelschermann F, Seifert M, et al. Predictors of permanent pacemaker implantation after transcatheter aortic valve implantation for aortic stenosis using Medtronic new generation self-expanding CoreValve Evolut R. Heart Vessels. 2019;34(2):360-367.
20. Biviano AB, Nazif T, Dizon J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights From the Placement of Aortic Transcatheter Valve (PARTNER) Trial. Circ Cardiovasc Interv. 2016;9(1):e002766.
21. Roten L, Wenaweser P, Delacrétaz E, et al. Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol. 2010;106(10):1473-1480.
22. Guetta V, Goldenberg G, Segev A, et al. Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving System. Am J Cardiol. 2011;108(11):1600-1605.
23. Bleiziffer S, Ruge H, Hörer J, et al. Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv. 2010;3(5):524-530.
24. D’Ancona G, Pasic M, Unbehaun A, Hetzer R. Permanent pacemaker implantation after transapical transcatheter aortic valve implantation. Interact Cardiovasc Thorac Surg. 2011;13(4):373-376.
25. Fraccaro C, Buja G, Tarantini G, et al. Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol. 2011;107(5):747-754.
26. Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation. 2011;123(9):951-960.
27. Saia F, Lemos PA, Bordoni B, et al. Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv. 2012;79(5):712-719.
28. Mouillet G, Lellouche N, Lim P, et al. Patients without prolonged QRS after TAVI with CoreValve device do not experience high-degree atrio-ventricular block. Catheter Cardiovasc Interv. 2013;81(5):882-887.
29. Schroeter T, Linke A, Haensig M, et al. Predictors of permanent pacemaker implantation after Medtronic CoreValve bioprosthesis implantation. Europace. 2012;14(12):1759-1763.
30. Lange P, Greif M, Vogel A, et al. Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention. 2014;9(10):1151-1157.
31. Hayashida K, Morice MC, Chevalier B, et al. Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol. 2012;59(6):566-571.
32. Akin I, Kische S, Paranskaya L, et al. Predictive factors for pacemaker requirement after transcatheter aortic valve implantation. BMC Cardiovasc Disord. 2012;12:87.
33. Bagur R, Rodés-Cabau J, Gurvitch R, et al. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012;5(5):540-551.
34. Calvi V, Conti S, Pruiti GP, et al. Incidence rate and predictors of permanent pacemaker implantation after transcatheter aortic valve implantation with self-expanding CoreValve prosthesis. J Interv Card Electrophysiol. 2012;34(2):189-195.
35. De Carlo M, Giannini C, Bedogni F, et al. Safety of a conservative strategy of permanent pacemaker implantation after transcatheter aortic CoreValve implantation. Am Heart J. 2012;163(3):492-499.
36. Muñoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, et al. Factors predicting and having an impact on the need for a permanent pacemaker after CoreValve prosthesis implantation using the new Accutrak delivery catheter system. JACC Cardiovasc Interv. 2012;5(5):533-539.
37. Ledwoch J, Franke J, Gerckens U, et al. Incidence and predictors of permanent pacemaker implantation following transcatheter aortic valve implantation: analysis from the German transcatheter aortic valve interventions registry. Catheter Cardiovasc Interv. 2013;82(4):E569-E577.
38. Chorianopoulos E, Krumsdorf U, Pleger ST, Katus HA, Bekeredjian R. Incidence of late occurring bradyarrhythmias after TAVI with the self-expanding CoreValve(®) aortic bioprosthesis. Clin Res Cardiol. 2012;101(5):349-355.
39. Pollari F, Großmann I, Vogt F, et al. Risk factors for atrioventricular block after transcatheter aortic valve implantation: a single-centre analysis including assessment of aortic calcifications and follow-up. Europace. 2019;21(5):787-795.
40. Kim WJ, Ko YG, Han S, et al. Predictors of permanent pacemaker insertion following transcatheter aortic valve replacement with the CoreValve Revalving system based on computed tomography analysis: an Asian multicenter registry study. J Invasive Cardiol. 2015;27(7):334-340.
41. Du F, Zhu Q, Jiang J, Chen H, Liu X, Wang J. Incidence and predictors of permanent pacemaker implantation in patients who underwent transcatheter aortic valve replacement: observation of a Chinese population. Cardiology. 2020;145(1):27-34.
42. Bisson A, Bodin A, Herbert J, et al. Pacemaker implantation after balloon- or self-expandable transcatheter aortic valve replacement in patients with aortic stenosis. J Am Heart Assoc. 2020;9(9):e015896.
43. Waksman R, Craig PE, Torguson R, et al. Transcatheter aortic valve replacement in low-risk patients with symptomatic severe bicuspid aortic valve stenosis. JACC Cardiovasc Interv. 2020;13(9):1019-1027.
44. Vlastra W, Chandrasekhar J, Muñoz-Garcia AJ, et al. Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration. Eur Heart J. 2019;40(5):456-465.
45. Siontis GC, Jüni P, Pilgrim T, et al. Predictors of permanent pacemaker implantation in patients with severe aortic stenosis undergoing TAVR: a meta-analysis. J Am Coll Cardiol. 2014;64(2):129-140.
46. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA. 2014;311(15):1503-1514.
47. Barbanti M. Early Outcomes of the Evolut R transcatheter aortic valve: a new technology between achieved goals and desirable improvements. JACC Cardiovasc Interv. 2017;10(3):283-285.
48. De Torres-Alba F, Kaleschke G, Diller GP, et al. Changes in the pacemaker rate after transition from Edwards SAPIEN XT to SAPIEN 3 transcatheter aortic valve implantation: the critical role of valve implantation height. JACC Cardiovasc Interv. 2016;9(8):805-813.
49. Athappan G, Patvardhan E, Tuzcu EM, et al. Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol. 2013;61(15):1585-1595.
50. Bernardi FL, Ribeiro HB, Carvalho LA, et al. Direct transcatheter heart valve implantation versus implantation with balloon predilatation: insights from the Brazilian Transcatheter Aortic Valve Replacement Registry. Circ Cardiovasc Interv. 2016;9(8):e003605.
51. Webster M, Pasupati S, Lever N, Stiles M. Safety and feasibility of a novel active fixation temporary pacing lead. J Invasive Cardiol. 2018;30(5):163-167.